You appear to be offline. Some data may be unavailable until your connection is restored.
Description
Abbott Laboratories is a multinational healthcare company that discovers, develops, manufactures and markets a broad range of medical products, including pharmaceuticals, branded generic medicines, diagnostic instruments and tests, nutritional foods and supplements, and medical devices such as cardiovascular, diabetes‑care and neuromodulation technologies. It operates primarily in the health‑care sector, with four main segments—Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Medical Devices—serving patients and providers in more than 160 countries. Abbott is a market leader in several areas, notably continuous glucose monitoring (FreeStyle Libre), point‑of‑care diagnostics, and a variety of nutrition brands, and it ranks among the largest U.S. health‑care firms by revenue and global footprint.
Quarterly EarningsQuarterly earnings results, including reported and estimated earnings per share (EPS), for the most recent fiscal quarters.Surprise compares reported EPS with the prior estimate.
| Quarter | DateReport date | EPSReported EPS |
|---|---|---|
| Q3 FY26 | Oct 21, 2026 | — |
| Q2 FY26 | Jul 16, 2026 | $1.31 |
| Q1 FY26 | Apr 16, 2026 | $1.15 |
| Q4 FY25 | Jan 22, 2026 | $1.50 |
| Q3 FY25 | Oct 15, 2025 | $1.30 |
Stay ahead of ABT earnings
Get reminders ahead of ABT's next earnings report, so you always know when results are coming.